NEETPGAI
BlogPricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Subjects
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Help Center

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/OBG/Preterm Labor
    Preterm Labor
    medium
    baby OBG

    A 28-year-old primigravida at 32 weeks of gestation presents with regular uterine contractions (4 contractions in 20 minutes) and cervical dilation of 2 cm. Fetal heart rate is reassuring. What is the drug of choice for tocolysis in this patient?

    A. Indomethacin
    B. Terbutaline
    C. Nifedipine
    D. Magnesium sulfate

    Explanation

    ## Tocolytic Agents in Preterm Labor **Key Point:** Nifedipine (a calcium channel blocker) is the first-line tocolytic agent in preterm labor between 24–34 weeks of gestation, particularly in the absence of contraindications. ### Rationale for Nifedipine Nifedipine is preferred because it: - Has the best safety profile with minimal maternal and fetal side effects - Does not require continuous fetal monitoring or maternal serum level checks - Can be administered orally (immediate-release formulation) - Reduces neonatal morbidity and mortality when used for fetal neuroprotection - Has no contraindication in most clinical scenarios ### Comparison of Tocolytic Agents | Agent | Mechanism | Onset | Route | Maternal Side Effects | Preferred Gestational Age | |-------|-----------|-------|-------|----------------------|-------------------------| | **Nifedipine** | Calcium channel blocker | 10–20 min | Oral/SL | Headache, flushing, hypotension (mild) | 24–34 weeks (first-line) | | Indomethacin | NSAID/COX inhibitor | 30 min | Oral/IV | GI upset, renal dysfunction | <32 weeks (short-term) | | Magnesium sulfate | NMDA antagonist | Immediate | IV | Flushing, nausea, weakness | Neuroprotection at <32 weeks | | Terbutaline | β₂-agonist | 5–10 min | SC/IV | Tachycardia, tremor, hyperglycemia | Rarely used now | **High-Yield:** Nifedipine is superior to β₂-agonists (terbutaline) and has a better side-effect profile than indomethacin for routine tocolysis. Magnesium sulfate is reserved primarily for neuroprotection, not as a first-line tocolytic. **Clinical Pearl:** In this patient at 32 weeks with no contraindications, immediate-release nifedipine 10–20 mg orally every 20–30 minutes (up to 3 doses) is the standard approach, followed by maintenance therapy if needed. **Warning:** Indomethacin should be avoided after 32 weeks due to risk of premature ductus arteriosus closure and oligohydramnios. Terbutaline carries maternal cardiovascular risks and is no longer recommended as first-line therapy. [cite:ACOG Practice Bulletin 127; Cunningham OB 26e Ch 42]

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free More OBG Questions